P32 Sodium Phosphate
Loading...P32 Sodium Phosphate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Not for intravascular injection.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections.
Radioactive phosphorous works by local irradiation by beta emission.
History
There is currently no drug history available for this drug.
Other Information
AnazaoHealth’s compounded P32 Chromic Phosphate is supplied as a sterile, nonpyrogenic aqueous solution. It contains 30 % dextrose solution, 1 mg sodium acetate, 2 % benzyl alcohol added as a preservative. Sodium hydroxide or hydrochloric acid may be added for pH adjustment.
Sources
P32 Sodium Phosphate Manufacturers
-
Anazaohealth Corporation
![P32 Sodium Phosphate Injection, Suspension [Anazaohealth Corporation]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
P32 Sodium Phosphate | Anazaohealth Corporation
Shake the vial well before injection.
For intraperitoneal instillation, administer 10-20 mCi
For intrapleural instillation, administer 6 to 12 mCi
Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm.
Login To Your Free Account